NEWRON PHARMACEUTICALS

Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. Xadago® (safinamide) has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland and the USA, and is commercialized by Newron’s Partner Zambon. US WorldMeds holds the commercialization rights in the USA. Meiji Seika, in collaboration with Eisai, has the rights ... to develop and commercialize the compound in Japan and other key Asian territories. In addition to Xadago® for Parkinson’s disease, Newron has a strong pipeline of promising treatments for rare disease patients at various stages of clinical development, including sarizotan for patients with Rett syndrome and ralfinamide for patients with specific rare pain indications. Newron is also developing Evenamide as the potential first add-on therapy for the treatment of patients with positive symptoms of schizophrenia. Founded in 1999, Newron is headquartered in Bresso, near Milan, Italy, with a subsidiary in Morristown, NJ, USA. The Company is listed on the SIX Swiss Exchange, trading symbol NWRN.

#SimilarOrganizations #People #Financial #Website #More

NEWRON PHARMACEUTICALS

Social Links:

Industry:

Biopharma Biotechnology Health Care Medical

Founded:

1999-01-01

Address:

Bresso, Lombardia, Italy

Country:

Italy

Website Url:

http://www.newron.com

Total Employee:

11+

Status:

Active

Contact:

+39026103461

Email Addresses:

[email protected]

Total Funding:

129.43 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Font Awesome Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail

Similar Organizations

accent-therapeutics-logo

Current Advisors List

not_available_image

Luca Benatti Member of the Board of Directors @ Newron Pharmaceuticals
Board_member

Current Employees Featured

stefan-weber_image

Stefan Weber
Stefan Weber CEO @ Newron Pharmaceuticals
CEO

ravi-anand_image

Ravi Anand
Ravi Anand CMO @ Newron Pharmaceuticals
CMO

roberto-galli_image

Roberto Galli
Roberto Galli Vice President Finance @ Newron Pharmaceuticals
Vice President Finance
2012-07-01

Founder

not_available_image

Luca Benatti

Stock Details

Company's stock symbol is SIX:NWRN

Acquisitions List

Date	Company	Article	Price
2012-06-13	NeuroNova	NeuroNova acquired by Newron Pharmaceuticals	N/A
2008-02-11	Hunter-Fleming Ltd	Hunter-Fleming Ltd acquired by Newron Pharmaceuticals	N/A

Investors List

tvm-capital_image

Official Site Inspections

http://www.newron.com Semrush global rank: 3.25 M Semrush visits lastest month: 5.08 K

Host Informations
Whois Informations

Loading ...